CHINA BIOLOGIC PRODS HLDGS I's ticker is CBPO and the CUSIP is G21515104. A total of 93 filers reported holding CHINA BIOLOGIC PRODS HLDGS I in Q2 2020. The put-call ratio across all filers is 0.10 and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $58,708,000 | +17.6% | 495,800 | +17.3% | 0.00% | 0.0% |
| Q4 2020 | $49,905,000 | -4.7% | 422,520 | -10.3% | 0.00% | 0.0% |
| Q3 2020 | $52,341,000 | +14.4% | 470,951 | +5.2% | 0.00% | 0.0% |
| Q2 2020 | $45,735,000 | +10.1% | 447,596 | +16.3% | 0.00% | 0.0% |
| Q1 2020 | $41,541,000 | -7.6% | 384,893 | -0.4% | 0.00% | 0.0% |
| Q4 2019 | $44,974,000 | -6.7% | 386,431 | -8.2% | 0.00% | 0.0% |
| Q3 2019 | $48,198,000 | +28.8% | 421,055 | +7.3% | 0.00% | 0.0% |
| Q2 2019 | $37,413,000 | -1.9% | 392,577 | -6.1% | 0.00% | 0.0% |
| Q1 2019 | $38,142,000 | +13.1% | 418,001 | -5.9% | 0.00% | 0.0% |
| Q4 2018 | $33,734,000 | -3.7% | 444,402 | +1.4% | 0.00% | 0.0% |
| Q3 2018 | $35,044,000 | -32.0% | 438,055 | -15.5% | 0.00% | 0.0% |
| Q2 2018 | $51,521,000 | -31.3% | 518,681 | -44.0% | 0.00% | -50.0% |
| Q1 2018 | $75,038,000 | +40.3% | 926,412 | +36.5% | 0.00% | +33.3% |
| Q4 2017 | $53,473,000 | -19.2% | 678,857 | -5.4% | 0.00% | 0.0% |
| Q3 2017 | $66,208,000 | – | 717,550 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|